A. Wilson

发表

Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.

B. Lipworth, A. Wilson, O. J. Dempsey, 2001, Chest.

Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial.

A. Wilson, L. Smith, J. Grossman, 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma.

B. Lipworth, A. Wilson, A. Wilson, 2000, The American journal of medicine.

Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype.

B. Lipworth, A. Wilson, O. J. Dempsey, 2000, The American journal of medicine.

Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis

B. Lipworth, A. Wilson, E. Sims, 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Predominant 4-hydroxylation of estradiol by constitutive cytochrome P450s in the female ACI rat liver.

A. Wilson, G. Reed, Gregory A. Reed, 2001, Carcinogenesis.

A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma

B. Lipworth, A. Wilson, O. J. Dempsey, 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Effects of low and high doses of inhaled flunisolide and triamcinolone acetonide on basal and dynamic measures of adrenocortical activity in healthy volunteers.

B. Lipworth, A. Wilson, L. McFarlane, 1998, The Journal of clinical endocrinology and metabolism.

Inhaled corticosteroid therapy reduces the early morning peak in cortisol and aldosterone.

B. Lipworth, A. Struthers, A. Wilson, 1998, Clinical science.

Airway and systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with asthma

B. Lipworth, S. Fowler, A. Wilson, 2002, Thorax.

Combined mediator blockade or topical steroid for treating the unified allergic airway

B. Lipworth, A. Wilson, D. Menzies, 2007, Allergy.

Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis.

B. Lipworth, A. Wilson, E. Sims, 1998, The Journal of allergy and clinical immunology.

Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis.

B. Lipworth, A. Wilson, E. Sims, 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma.

B. Lipworth, A. Wilson, O. J. Dempsey, 2000, American journal of respiratory and critical care medicine.

Altered secretory responsiveness of BRIN-BD11 cells cultured under hyperglycaemic conditions is not readily reversed by subsequent culture in lower glucose concentrations.

A. Wilson, P. Flatt, C. Barnett, 1997, Advances in experimental medicine and biology.

Are Needle-Free Injections a Useful Alternative for Growth Hormone Therapy in Children? Safety and Pharmacokinetics of Growth Hormone Delivered by a New Needle-Free Injection Device Compared to a Fine Gauge Needle

H. Dörr, A. Wilson, B. Otten, 2003, Journal of pediatric endocrinology & metabolism : JPEM.

A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis

B. Lipworth, A. Wilson, E. Sims, 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Subjective and objective markers of treatment response in patients with seasonal allergic rhinitis.

B. Lipworth, A. Wilson, O. J. Dempsey, 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Montelukast and Churg-Strauss syndrome.

B. Lipworth, A. Wilson, 2001, Thorax.

Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults

B. Lipworth, A. Wilson, M. Devlin, 1998, European Journal of Clinical Pharmacology.

Effects of mediator antagonism on mannitol and adenosine monophosphate challenges

S. Anderson, B. Lipworth, J. Brannan, 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.

B. Lipworth, S. Fowler, A. Wilson, 2001, British journal of clinical pharmacology.

The effect of inhaled lidocaine–hydrofluoroalkane 134a in prednisone-dependent eosinophilic bronchitis

M. Duong, A. Wilson, F. Hargreave, 2008, European Respiratory Journal.

Dose-response comparison of systemic bioactivity with inhaled budesonide and triamcinolone acetonide in asthmatic adults.

B. Lipworth, A. Wilson, A. Wilson, 1998, The Journal of allergy and clinical immunology.

Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics.

B. Lipworth, A. Wilson, L. McFarlane, 1997, American journal of respiratory and critical care medicine.

Short-term dose-response relationships for the relative systemic effects of oral prednisolone and inhaled fluticasone in asthmatic adults.

B. Lipworth, A. Wilson, 1999, British journal of clinical pharmacology.

Modulation of cholestane-3 beta,5 alpha,6 beta-triol toxicity by butylated hydroxytoluene, alpha-tocopherol and beta-carotene in newborn rat kidney cells in vitro.

A. Wilson, N. O'Brien, R. M. Sisk, 1997, The British journal of nutrition.

Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers

B. Lipworth, A. Wilson, L. McFarlane, 1997, European Journal of Clinical Pharmacology.

Dose response with fluticasone propionate on adrenocortical activity and recovery of basal and stimulated responses after stopping treatment

B. Lipworth, A. Wilson, E. Sims, 1999, Clinical endocrinology.

Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic adults.

B. Lipworth, A. Wilson, I. Aziz, 2000, Chest.

Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity.

B. Lipworth, A. Wilson, L. McFarlane, 1998, The Journal of allergy and clinical immunology.

Spacer devices increase dose of inhaled corticosteroids delivered

B. Lipworth, A. Wilson, O. J. Dempsey, 1999, BMJ.

Systemic bioactivity profiles of oral prednisolone and nebulized budesonide in adult asthmatics.

B. Lipworth, A. Wilson, L. McFarlane, 1998, Chest.

Combination chemoprevention of rat mammary carcinogenesis by indomethacin and butylated hydroxytoluene.

A. Wilson, D. Mccormick, 1986, Cancer research.

The effect of β2‐adrenoceptor haplotypes on bronchial hyper‐responsiveness in patients with asthma

I. Hall, B. Lipworth, A. Wilson, 2006, Allergy.

Asthma and Cushing's syndrome.

B. Lipworth, R. Jung, A. Wilson, 2000, Chest.

Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler.

B. Lipworth, A. Wilson, O. J. Dempsey, 1999, Chest.

Effects of leukotriene receptor antagonist therapy in patients with chronic rhinosinusitis in a real life rhinology clinic setting.

B. Lipworth, A. Wilson, Q. Gardiner, 2001, Rhinology.

Comparative in vivo lung delivery of hydrofluoroalkane-salbutamol formulation via metered-dose inhaler alone, with plastic spacer, or with cardboard tube.

B. Lipworth, S. Fowler, A. Wilson, 2001, Chest.